The economic benefits of selling Feliferon are provided by a sufficiently high cost per packaging unit, which allows the selling company to get a large margin on sales.
Feliferon has obvious benefits regarding the cost of treatment. The cost of the packaging is comparable with the most commonly used close analogues.
The manufacturer provides active comprehensive support of Feliferon sales which gradually forms the readiness of the market to purchase the drug in mass volumes, allowing the seller company to increase the efficiency of its sales.